Sigma Research
TwitterFacebookVimeo

Motivations and barriers to PrEP use for black men who have sex with men (MSM), aged 18-45 in London

Duration: April 2016 - September 2016

HIV Pre-exposure prophylaxis (PrEP) is an intervention utilising anti-retroviral medications in an HIV negative person to reduce their risk of contracting HIV. Most often taken as a daily tablet, PrEP represents a significant step in the diversification of prevention options available to those most at risk of HIV infection. The PROUD study in England demonstrated 86% effectiveness at a programme level, and a much higher efficacy for individuals who took the drug consistently. 

While MSM experience a significantly higher prevalence of HIV compared to the general population, health inequalities exist among MSM. A recent meta-analysis demonstrated that black MSM were significantly more likely to have HIV than white MSM despite reporting similar HIV risk behaviours. In addition, this group was less likely to have knowledge of PrEP and less likely to access antiretroviral therapy if HIV positive. HIV incidence among MSM peaks between the ages of 18 and 45, suggesting that this age group would likely have the greatest benefit from a future PrEP programme.

In this small pilot project we therefore aim to understand the motivations and barriers to PrEP use among black MSM aged 18-45. We will complete 25 semi-structured interviews with MSM who describe their ethnicity as black, sampled based on a variety of demographic and health service use characteristics.

If you're interested in taking part, contact Charlie Witzel the lead researcher for this project.

This small pilot project is supported by the Wellcome Trust [200172/Z/15/Z]